$7.1 Million Revenue, Highly Profitable, Full-Service Toxicology/Medical Lab in the Northeast

Medical Labs

American HealthCare Capital is pleased to exclusively present a full spectrum reference laboratory for sale in the Northeast. Established in 2017, this is a state-of-the-art, full-service CLIA certified laboratory. The lab offers the following testing services and capabilities: Prescription Drug Monitoring, Presumptive and Confirmatory Toxicology, and PCR Infectious Disease, Chemistry, Wound, Genetic, and Molecular testing.

The company’s payer mix is approximately 80% Medicaid, 5% Medicare, 10% private insurance, and 5% private pay. Their payer mix was 95% Toxicology and 5% Other Testing. Gross revenues were $7.1 million with an adjusted EBITDA of nearly $3 million. The company expects to exceed 2023 results in 2024.

Averaging approximately 8,500 Toxicology tests per month, the lab is operating with a gross operating margin of approximately 42%. They are poised to grow through expansion of UTI testing to their toxicology base, as well as new test offerings in the Molecular and Genetics sectors.

The staff is expected to stay on post-acquisition, while the owners will assist during a transitional period as needed.

The asking price for this opportunity is $18 million.

If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.